Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

SAN DIEGO & MENLO PARK, Calif.–(BUSINESS WIRE)—- $ILMN #ILMN–Illumina, Inc. (NASDAQ: ILMN) and GRAIL, a healthcare company whose mission is focused on multi-cancer early detection, today announced they have entered into a definitive agreement under which Illumina will acquire GRAIL for cash and stock consideration of $8 billion upon closing of the transaction. In addition, GRAIL stockholders will receive future payments representing a tiered single digit percentage of certain GRAIL-related revenues. The ag

Click to view original post

Advertise With Us